Novartis Investigative Site

Tokushima, Tokushima 770-8503

0 studies enrolling now · 3 studies all time

What they study most

Chronic Heart Failure, Metastatic Renal Cell Carcinoma, Sporadic Inclusion Body Myositis

Studies at this site

• Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients — Completed
• Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure — Completed
• RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib — Completed